• Contact us
  • E-Submission

Ewha Med J : The Ewha Medical Journal

OPEN ACCESS
mobile search button mobile menu button
Search
Advanced Search
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Articles

Page Path

Review Article

Diagnosis and Treatment of Moyamoya Disease

Eui Kyo Seo
The Ewha Medical Journal 2013;36(1):9-17. Published online: March 25, 2013

Department of Neurosurgery, Ewha Womans University School of Medicine, Seoul, Korea.

Corresponding author: Eui Kyo Seo, Department of Neurosurgery, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea. Tel: 82-2-2650-2650, Fax: 82-2-2650-2634, drekseo@ewha.ac.kr
• Received: January 26, 2013   • Accepted: March 2, 2013

Copyright © 2013. Ewha Womans University School of Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 51 Views
  • 0 Download
  • 3 Crossref
prev next

Full Article

Download PDF Download PDF
  • Moyamoya disease is a cerebrovascular disease of unknown etiology, which is characterized by bilateral stenosis or occlusion at terminal portion of internal carotid artery and at proximal portion of anterior cerebral artery and/or middle cerebral artery and abnormal vascular network in the vicinity of the arterial occlusions. It occurs frequently in Asian countries, particularly in Korea and Japan, but is rare in Western countries. To establish the etiology of moyamoya disease, much about the pathology from autopsies, factors involved in its pathogenesis, and its genetics have been studied. It may occur at any age from childhood to adulthood and in general, initial manifestation is cerebral ischemic symptoms in children and intracranial hemorrhage symptoms in adults. Because it progress and cause recurrent stroke, early diagnosis and proper management has been recognized. Cerebral angiography is essential for definitive diagnosis and treatment plan. Magnetic resonance imaging/magnetic resonance angiography is useful for diagnosis and follow-up tools after revascularization. Evaluation of the cerebral hemodynamics by single photon emission computed tomography and positron emission tomography is useful for diagnosis and assessment of the severity of cerebral ischemia in moyamoya patients. Surgical revascularization is effective for moyamoya disease manifesting as ischemic symptoms, to prevent further ischemia and infarction. In hemorrhagic type moyamoya disease, revascularization can be considered. Direct bypass, indirect synangiosis and combined methods are used. Outcomes of revascularization are excellent in preventing transient ischemic attacks in most patients.
  • Keywords: Cerebral hemorrhage; Cerebral ischemia; Moyamoya disease; Revascularization
  • 1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299.
  • 2. Natori Y, Ikezaki K, Matsushima T, Fukui M. 'Angiographic moyamoya' its definition, classification, and therapy. Clin Neurol Neurosurg 1997;99:Suppl 2. S168-S172.
  • 3. Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 2005;76:256-259.
  • 4. Suzuki J, Kodama N. Moyamoya disease: a review. Stroke 1983;14:104-109.
  • 5. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005;36:2148-2153.
  • 6. Nakashima H, Meguro T, Kawada S, Hirotsune N, Ohmoto T. Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg 1997;99:Suppl 2. S156-S161.
  • 7. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C. Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 1998;29:625-630.
  • 8. Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 1992;32:883-886.
  • 9. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997;99:Suppl 2. S1-S5.
  • 10. Ohki K, Hoshino H, Nogawa S, Yamaguchi K. Ministry of Health, Labour and Welfare2006 Databases evaluation by the Research Committee on Moyamoya Disease (Spontaneous occlusion of the circle of Willis). Research on spontaneous occlusion of the circle of Willis 2007;Tokyo, Ministry of Health, Labour and Welfare. 19-25.
  • 11. Ikezaki K. American Association of Neurological SurgeonsClinical manifestations: epidemiology, symptoms and signs, laboratory findings. Moyamoya disease 2001;Rolling Meadows (IL), American Association of Neurological Surgeons. 43-54.
  • 12. Yamaguchi K, Nogawa S, Fukuuchi Y. National survey on spontaneous occlusion of the circle of Willis (moyamoya disease). Shinkei Naika 2001;54:319-327.
  • 13. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008;79:900-904.
  • 14. Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology 2000;20:Suppl. S61-S64.
  • 15. Malek AM, Connors S, Robertson RL, Folkman J, Scott RM. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg 1997;27:182-189.
  • 16. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, et al. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 1998;89:623-629.
  • 17. Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta KI, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006;77:1025-1029.
  • 18. Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg 2005;103:5 Suppl. 439-442.
  • 19. Fujimura M, Mugikura S, Shimizu H, Tominaga T. Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease. No Shinkei Geka 2006;34:801-809.
  • 20. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994;81:843-850.
  • 21. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K, Ikezaki K, et al. Cerebral hemodynamics and metabolism in moyamoya disease--a positron emission tomography study. Clin Neurol Neurosurg 1997;99:Suppl 2. S74-S78.
  • 22. Saito N, Nakagawara J, Nakamura H, Teramoto A. Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study. Ann Nucl Med 2004;18:323-331.
  • 23. Kuroda S, Kamiyama H, Isobe M, Houkin K, Abe H, Mitsumori K. Cerebral hemodynamics and "re-build-up" phenomenon on electroencephalogram in children with moyamoya disease. Childs Nerv Syst 1995;11:214-219.
  • 24. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke 1998;29:1347-1351.
  • 25. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-up study. Stroke 1999;30:2272-2276.
  • 26. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 2000;93:976-980.
  • 27. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K, Matsushima T, et al. Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 1997;28:701-707.
  • 28. Miyamoto S. Japan Adult Moyamoya Trial GroupStudy design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset: the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 2004;44:218-219.
  • 29. Park EK, Lee YH, Shim KW, Choi JU, Kim DS. Natural history and progression factors of unilateral moyamoya disease in pediatric patients. Childs Nerv Syst 2011;27:1281-1287.
  • 30. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 1992;77:84-89.
  • 31. Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 1997;99:Suppl 2. S142-S145.
  • 32. Irikura K, Miyasaka Y, Kurata A, Tanaka R, Fujii K, Yada K, et al. A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 1996;138:1282-1286.
  • 33. Iwama T, Morimoto M, Hashimoto N, Goto Y, Todaka T, Sawada M. Mechanism of intracranial rebleeding in moyamoya disease. Clin Neurol Neurosurg 1997;99:Suppl 2. S187-S190.
  • 34. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K. Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochir (Wien) 1996;138:1287-1294.
  • 35. Aoki N. Cerebrovascular bypass surgery for the treatment of moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol 1993;40:372-377.
  • 36. Kawaguchi S, Okuno S, Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 2000;93:397-401.
  • 37. Okada Y, Shima T, Matsumura S, Nishida M, Yamada T, Okita S. Pathophysiological studies in moyamoya disease by rCBF and cortical artery pressure measurements in comparison to those in ICA or MCA occlusion. No To Shinkei 1988;40:899-903.
  • 38. Matsushima Y, Inaba Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Childs Brain 1984;11:155-170.
  • 39. Sainte-Rose C, Oliveira R, Puget S, Beni-Adani L, Boddaert N, Thorne J, et al. Multiple bur hole surgery for the treatment of moyamoya disease in children. J Neurosurg 2006;105:6 Suppl. 437-443.
  • 40. Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996;38:1120-1126.
  • 41. Nagata S, Matsushima T, Morioka T, Matsukado K, Mihara F, Sasaki T, et al. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients. Neurosurgery 2006;59:830-837.
  • 42. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Research Committee on Moyamoya Disease in JapanRadiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 2007;38:1430-1435.
  • 43. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009;111:927-935.
  • 44. Andaluz N, Choutka O, Zuccarello M. Trends in the management of adult moyamoya disease in the United States: results of a nationwide survey. World Neurosurg 2010;73:361-364.
Fig. 1
A left carotid angiography (A, anteroposterior view; B, lateral view) shows severe stenosis in terminal portion of internal carotid artery and proximal middle cerebral artery and occlusion of proximal portion of anterior cerebral artery and demonstrates basal collateral vessels. A right carotid angiography (C, anteroposterior view; D, lateral view) demonstrates stenosis of proximal middle cerebral artery and occlusion in proximal portion of anterior cerebral artery.
emj-36-9-g001.jpg
Fig. 2
Initial angiography (A) shows mild stenosis in terminal portion of internal carotid artery and well visualized middle cerebral artery. After 2 years, angiography (B) demonstrate that middle cerebral artery is not visualized and basal there are collateral vessels (arrow head) from posterior cerebral artery. Posterior cerebral artery is occluded and collateral vessel is disappeared after 6 months later (C).
emj-36-9-g002.jpg
Fig. 3
A T2 weighted axial magnetic resonance image (A) shows cerebral infarction in right temporo-occipital areas. An axial T1 weighted image (B) demonstrates multiple signal voids of the hypertrophied moyamoya collateral in the basal ganglia.
emj-36-9-g003.jpg
Fig. 4
Basal single photon emission computed tomography (SPECT) (A) and acetazolamide SPECT (B) show decreased blood flow and reserve capacity in left frontal lobe.
emj-36-9-g004.jpg
Fig. 5
After revascularization, cerebral blood flow is increased in left frontal lobe.
emj-36-9-g005.jpg

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Structural equation model based on salutogenesis theory for evaluating factors affecting health-related quality of life in adolescents with moyamoya disease
      Won-oak Oh, Insun Yeom, Sung-Hyun Lim
      Scientific Reports.2022;[Epub]     CrossRef
    • Factors Influencing Health Behavior Compliance in Adult Moyamoya Patients
      Bo Eun Kim, Ju-Eun Song
      Journal of Korean Academy of Nursing.2021; 51(1): 80.     CrossRef
    • Stress and mood of adults with moyamoya disease: A cross‐sectional study
      Yong Sook Yang, Gi Wook Ryu, Insun Yeom, Kyu Won Shim, Mona Choi
      Nursing & Health Sciences.2020; 22(3): 795.     CrossRef

    Download Citation

    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:

    Include:

    Diagnosis and Treatment of Moyamoya Disease
    Ewha Med J. 2013;36(1):9-17.   Published online March 25, 2013
    DOI: https://doi.org/10.12771/emj.2013.36.1.9
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Diagnosis and Treatment of Moyamoya Disease
    Ewha Med J. 2013;36(1):9-17.   Published online March 25, 2013
    DOI: https://doi.org/10.12771/emj.2013.36.1.9
    Close

    Figure

    • 0
    • 1
    • 2
    • 3
    • 4

    Related articles

    Diagnosis and Treatment of Moyamoya Disease
    Image Image Image Image Image
    Fig. 1 A left carotid angiography (A, anteroposterior view; B, lateral view) shows severe stenosis in terminal portion of internal carotid artery and proximal middle cerebral artery and occlusion of proximal portion of anterior cerebral artery and demonstrates basal collateral vessels. A right carotid angiography (C, anteroposterior view; D, lateral view) demonstrates stenosis of proximal middle cerebral artery and occlusion in proximal portion of anterior cerebral artery.
    Fig. 2 Initial angiography (A) shows mild stenosis in terminal portion of internal carotid artery and well visualized middle cerebral artery. After 2 years, angiography (B) demonstrate that middle cerebral artery is not visualized and basal there are collateral vessels (arrow head) from posterior cerebral artery. Posterior cerebral artery is occluded and collateral vessel is disappeared after 6 months later (C).
    Fig. 3 A T2 weighted axial magnetic resonance image (A) shows cerebral infarction in right temporo-occipital areas. An axial T1 weighted image (B) demonstrates multiple signal voids of the hypertrophied moyamoya collateral in the basal ganglia.
    Fig. 4 Basal single photon emission computed tomography (SPECT) (A) and acetazolamide SPECT (B) show decreased blood flow and reserve capacity in left frontal lobe.
    Fig. 5 After revascularization, cerebral blood flow is increased in left frontal lobe.

    Fig. 1

    Fig. 2

    Fig. 3

    Fig. 4

    Fig. 5

    Diagnosis and Treatment of Moyamoya Disease
    Ewha Med J : The Ewha Medical Journal

    ABOUT

    BROWSE ARTICLES 

    JOURNAL POLICIES

    FOR CONTRIBUTORS 

    © Ewha Womans University College of Medicine.
    TOP